Filing Details
- Accession Number:
- 0000905148-24-003412
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-23 18:56:14
- Reporting Period:
- 2024-12-23
- Accepted Time:
- 2024-12-23 18:56:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1865494 | Io Biotech Inc. | IOBT | Pharmaceutical Preparations (2834) | 870909276 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1890736 | Mai-Britt Zocca | C/O Io Biotech, Inc. Ole Maaloes Vej 3 Copenhagen G7 2200 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-23 | 12,500 | $0.81 | 49,891 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 26,580 | Indirect | Zocca Consulting ApS |
Footnotes
- The actual purchase price is $0.809556 per share of Common Stock, which has been rounded due to systematic character limitations.
- The reporting person is the sole owner of Zocca Consulting ApS and, in such capacity, may be deemed to beneficially own the shares held directly by Zocca Consulting ApS. The reporting person disclaims beneficial ownership of the shares held directly by Zocca Consulting ApS except to the extent of her pecuniary interest therein.
Billionaire Hedge Funds
